Biotech could be a US$4 trillion industry in 10 years. Pic via Getty Images
Health & Biotech
Steve Jobs used to say that the most significant advancements of the 21st century would arise from the convergence of biology and technology.
He’s not far off the mark as the global biotech market is poised to triple to USD 3,995.22 billion (that’s $4 trillion) by 2032 – according to data from Precedence Research.
The market is witnessing unprecedented growth due to the increasing demand for food, prevalence of chronic diseases, and advancements in technology.
The research suggests that DNA sequencing and genetic engineering technology would be one area to see increasing investments over the next few years. This is a segment of biotech where drugs are developed using living cells, designed to target specific proteins, cells, and genetic pathways.
These drugs target a wide range of diseases, including cancer, autoimmune disorders, and infectious diseases. They’ve also been used to treat rare genetic disorders, such as cystic fibrosis and hemophilia.
Another example of genetic engineering is the use of DNA technology to produce insulin for the treatment of diabetes.
Recombinant DNA technology involves inserting a human gene for insulin production into a bacterial or yeast cell. This method has revolutionised the treatment of diabetes and has made insulin more widely available and affordable.
Ark fund manager Cathie Wood has been a strong believer in genetic technologies, and her portfolio reflects her conviction.
In a filing last week, Wood added to the Ark fund 6 million more shares of genetics biotech firm, Ginkgo Bioworks, a company that’s been a favourite of hers for a while now. Ginkgo has ongoing programs in cell engineering and enzymes, amongst others.
Another segment of biotech that could see huge demand going forward is obesity drugs.
According to Morgan Stanley, the recent frenzy around Ozempic and Wegovy could see the weight-loss drugs sector surge to US$77 billion by 2030.
Ozempic and Wegovy work by mimicking the effects of GLP-1, a gut hormone that can help control blood-sugar levels and reduce appetite. (GLP stands for glucagon-like peptide.)
A recent survey in the US shows that nearly half of adults want to lose weight, and would be interested in taking a prescription drug to help them do so.
An estimated 42% of the American population meanwhile is classified as obese.
Swipe or scroll to reveal the full table. Click headings to sort.
| CODE | COMPANY | PRICE | 1 WEEK RETURN % | 1 MONTH RETURN % | 6 MONTH RETURN % | 1 YEAR RETURN % | MARKET CAP |
|---|---|---|---|---|---|---|---|
| BDX | Bcaldiagnostics | 0.15 | 3.45 | 114.29 | 141.94 | 76.47 | $29,852,577 |
| 1ST | 1St Group Ltd | 0.01 | 0.00 | 80.00 | 0.00 | -10.00 | $12,752,921 |
| AVE | Avecho Biotech Ltd | 0.01 | 25.00 | 50.00 | -28.57 | -46.43 | $15,135,146 |
| LDX | Lumos Diagnostics | 0.09 | 70.59 | 35.94 | 155.88 | 26.09 | $31,484,446 |
| BOT | Botanix Pharma Ltd | 0.19 | 18.75 | 35.71 | 183.58 | 137.50 | $248,709,442 |
| ADR | Adherium Ltd | 0.00 | 0.00 | 33.33 | 0.00 | -60.00 | $24,997,042 |
| AN1 | Anagenics Limited | 0.02 | 5.26 | 33.33 | -10.27 | -38.82 | $6,581,159 |
| RHT | Resonance Health | 0.07 | 14.04 | 30.00 | 10.17 | -16.67 | $29,955,379 |
| DOC | Doctor Care Anywhere | 0.06 | -5.00 | 26.67 | -8.06 | -79.27 | $20,898,608 |
| ATH | Alterity Therap Ltd | 0.01 | 14.29 | 23.08 | -5.88 | -46.67 | $17,079,283 |
| EZZ | EZZ Life Science | 0.62 | -9.56 | 23.00 | 78.26 | 73.24 | $26,904,150 |
| RNO | Rhinomed Ltd | 0.08 | 7.14 | 20.97 | -16.67 | -55.88 | $21,428,977 |
| GLH | Global Health Ltd | 0.15 | 0.00 | 20.00 | -16.67 | -57.14 | $8,707,430 |
| SHG | Singular Health | 0.05 | 28.95 | 16.67 | -53.33 | -71.18 | $5,511,100 |
| HGV | Hygrovest Limited | 0.05 | 2.17 | 14.63 | -32.86 | -28.79 | $9,884,598 |
| IPD | Impedimed Limited | 0.20 | -2.44 | 14.29 | 233.33 | 166.67 | $393,662,404 |
| ALC | Alcidion Group Ltd | 0.11 | -2.17 | 12.50 | -19.64 | -29.69 | $145,827,941 |
| ONE | Oneview Healthcare | 0.23 | 0.00 | 12.20 | 100.00 | 43.75 | $154,808,587 |
| ZNO | Zoono Group Ltd | 0.05 | -8.00 | 12.20 | -49.97 | -67.91 | $8,736,673 |
| CYP | Cynata Therapeutics | 0.15 | 0.00 | 11.54 | -52.46 | -65.48 | $26,046,609 |
| IRX | Inhalerx Limited | 0.04 | 0.00 | 11.43 | -35.00 | -50.00 | $7,400,911 |
| KZA | Kazia Therapeutics | 0.15 | 0.00 | 11.11 | 25.00 | -40.00 | $35,452,406 |
| S66 | Star Combo | 0.11 | -6.38 | 10.00 | -37.14 | -54.17 | $14,859,128 |
| RCE | Recce Pharmaceutical | 0.72 | 2.86 | 9.92 | 27.43 | -22.16 | $122,995,474 |
| AMT | Allegra Orthopaedics | 0.06 | 0.00 | 9.09 | -14.29 | -64.71 | $6,267,552 |
| CDX | Cardiex Limited | 0.18 | 9.09 | 9.09 | -38.98 | -47.83 | $23,707,781 |
| NXS | Next Science Limited | 0.60 | 0.00 | 9.09 | -17.81 | -37.50 | $133,169,883 |
| PNV | Polynovo Limited | 1.71 | 11.97 | 7.73 | -24.45 | -20.21 | $1,149,237,530 |
| PCK | Painchek Ltd | 0.03 | -9.38 | 7.41 | 3.57 | -3.33 | $36,992,702 |
| UBI | Universal Biosensors | 0.27 | -1.85 | 6.00 | -18.46 | -11.67 | $58,401,595 |
| CYC | Cyclopharm Limited | 2.30 | -1.29 | 5.99 | 47.91 | 58.62 | $219,483,403 |
| 4DX | 4Dmedical Limited | 0.72 | 19.17 | 5.93 | 78.75 | 5.15 | $239,867,138 |
| BPH | BPH Energy Ltd | 0.02 | 0.00 | 5.26 | 11.11 | 27.36 | $18,604,710 |
| SDI | SDI Limited | 0.86 | -1.15 | 4.88 | -7.53 | 1.18 | $101,630,028 |
| CHM | Chimeric Therapeutic | 0.04 | 18.92 | 4.76 | -40.54 | -68.57 | $20,117,312 |
| CU6 | Clarity Pharma | 0.96 | 8.47 | 4.35 | 15.66 | 50.00 | $178,538,613 |
| CAN | Cann Group Ltd | 0.13 | 4.17 | 4.17 | -31.89 | -55.79 | $53,160,496 |
| OPT | Opthea Limited | 0.62 | 10.71 | 2.48 | -31.11 | -50.79 | $261,609,283 |
| MDR | Medadvisor Limited | 0.23 | 9.52 | 2.22 | -9.80 | 43.75 | $122,876,727 |
| ACR | Acrux Limited | 0.05 | 2.13 | 2.13 | -21.31 | -23.81 | $13,256,071 |
| IMC | Immuron Limited | 0.08 | 6.76 | 1.28 | 1.28 | -13.19 | $17,996,069 |
| ALT | Analytica Limited | 0.00 | 0.00 | 0.00 | 0.00 | -33.33 | $4,613,801 |
| TSN | The Sust Nutri Grp | 0.01 | 0.00 | 0.00 | -44.44 | -92.86 | $1,409,029 |
| MEB | Medibio Limited | 0.00 | -33.33 | 0.00 | -33.33 | 0.00 | $5,150,594 |
| AHC | Austco Healthcare | 0.17 | 0.00 | 0.00 | 47.83 | 41.67 | $49,434,328 |
| AC8 | Auscann Grp Hlgs Ltd | 0.04 | 0.00 | 0.00 | 0.00 | -14.89 | $17,621,884 |
| BWX | BWX Limited | 0.20 | 0.00 | 0.00 | -11.11 | -72.97 | $39,997,500 |
| CTE | Cryosite Limited | 0.65 | 0.00 | 0.00 | -16.67 | -2.26 | $31,726,216 |
| MX1 | Micro-X Limited | 0.11 | 10.00 | 0.00 | -18.52 | -26.67 | $56,806,749 |
| MEM | Memphasys Ltd | 0.02 | 6.25 | 0.00 | 13.33 | -60.40 | $14,392,806 |
| TD1 | Tali Digital Limited | 0.00 | 0.00 | 0.00 | -60.00 | -80.00 | $3,295,156 |
| NTI | Neurotech Intl | 0.04 | -4.35 | 0.00 | -20.00 | -60.00 | $38,452,017 |
| MDC | Medlab Clinical Ltd | 6.60 | 0.00 | 0.00 | -5.04 | -43.15 | $15,071,113 |
| NOX | Noxopharm Limited | 0.04 | 5.88 | 0.00 | -65.71 | -85.31 | $10,228,328 |
| ARX | Aroa Biosurgery | 0.90 | 1.69 | 0.00 | -17.81 | 6.51 | $305,367,427 |
| ALA | Arovella Therapeutic | 0.05 | -2.08 | 0.00 | 38.24 | 74.07 | $40,487,166 |
| IDT | IDT Australia Ltd | 0.07 | -1.49 | 0.00 | -7.04 | -54.48 | $23,188,252 |
| OCC | Orthocell Limited | 0.39 | 0.00 | -1.28 | 1.32 | -4.94 | $75,961,682 |
| DXB | Dimerix Ltd | 0.07 | 2.86 | -1.37 | -43.63 | -54.20 | $28,420,016 |
| MVF | Monash IVF Group Ltd | 1.18 | -0.84 | -1.67 | 7.80 | 12.44 | $459,769,111 |
| AT1 | Atomo Diagnostics | 0.04 | 16.67 | -2.78 | -30.00 | -54.55 | $20,454,474 |
| ZLD | Zelira Therapeutics | 1.50 | -7.41 | -3.23 | 25.00 | -16.67 | $17,020,733 |
| ZLD | Zelira Therapeutics | 1.50 | -7.41 | -3.23 | 25.00 | -16.67 | $17,020,733 |
| NC6 | Nanollose Limited | 0.06 | -8.33 | -3.51 | -14.06 | -24.66 | $8,188,750 |
| LBT | LBT Innovations | 0.03 | 23.81 | -3.70 | -57.72 | -63.89 | $9,100,161 |
| TRU | Truscreen | 0.03 | -3.85 | -3.85 | -13.79 | -44.44 | $10,832,692 |
| EYE | Nova EYE Medical Ltd | 0.25 | -5.77 | -3.92 | -9.26 | 0.00 | $47,627,473 |
| PBP | Probiotec Limited | 2.57 | 0.78 | -5.17 | 12.72 | 12.72 | $209,001,153 |
| VLS | Vita Life Sciences.. | 1.48 | -1.33 | -5.43 | -2.63 | -28.50 | $80,931,918 |
| CAJ | Capitol Health | 0.24 | 4.35 | -5.88 | -14.29 | -26.15 | $260,563,022 |
| BIT | Biotron Limited | 0.03 | 14.29 | -5.88 | 14.29 | -44.00 | $27,058,347 |
| ATX | Amplia Therapeutics | 0.08 | -4.82 | -5.95 | -12.22 | -20.20 | $16,102,480 |
| IMU | Imugene Limited | 0.09 | 2.17 | -6.00 | -27.69 | -67.59 | $603,765,676 |
| LCT | Living Cell Tech. | 0.02 | 0.00 | -6.25 | 68.74 | 51.87 | $24,527,185 |
| VBS | Vectus Biosystems | 0.40 | -11.11 | -6.98 | -43.66 | -55.56 | $21,275,808 |
| OSX | Osteopore Limited | 0.07 | -5.26 | -7.10 | -39.33 | -67.64 | $11,618,897 |
| DVL | Dorsavi Ltd | 0.01 | 8.33 | -7.14 | -7.14 | 8.33 | $7,236,601 |
| ICR | Intelicare Holdings | 0.01 | 0.00 | -7.69 | -47.83 | -66.59 | $2,506,985 |
| IMM | Immutep Ltd | 0.30 | -1.67 | -7.81 | 17.51 | -9.20 | $356,191,863 |
| 1AD | Adalta Limited | 0.02 | 0.00 | -8.00 | -39.47 | -58.93 | $10,155,105 |
| CBL | Control Bionics | 0.08 | -1.27 | -8.24 | -51.25 | -61.95 | $8,192,713 |
| VTI | Vision Tech Inc | 0.22 | 4.76 | -8.33 | -37.14 | -37.14 | $6,977,788 |
| GSS | Genetic Signatures | 0.55 | -0.91 | -8.40 | -36.63 | -45.50 | $81,024,388 |
| NEU | Neuren Pharmaceut. | 12.42 | 3.07 | -8.61 | 69.90 | 127.06 | $1,603,587,115 |
| PAA | Pharmaust Limited | 0.07 | -2.67 | -8.75 | -14.12 | -9.88 | $25,460,571 |
| RSH | Respiri Limited | 0.03 | -28.57 | -9.09 | -35.48 | -34.78 | $30,828,726 |
| SOM | SomnoMed Limited | 0.94 | 3.87 | -9.62 | -23.58 | -23.89 | $76,138,570 |
| JTL | Jayex Technology Ltd | 0.01 | 0.00 | -10.00 | -18.18 | 50.00 | $2,531,507 |
| AGH | Althea Group | 0.04 | -4.55 | -10.64 | -19.23 | -67.69 | $16,647,113 |
| CMP | Compumedics Limited | 0.17 | 0.00 | -10.81 | -8.33 | -29.79 | $29,231,886 |
| TRP | Tissue Repair | 0.28 | -1.79 | -11.29 | 5.77 | -17.91 | $12,864,598 |
| OIL | Optiscan Imaging | 0.08 | -2.53 | -12.50 | -21.42 | -34.52 | $64,298,142 |
| PGC | Paragon Care Limited | 0.23 | 2.27 | -13.46 | -28.57 | -35.71 | $145,056,104 |
| PSQ | Pacific Smiles Grp | 1.33 | -3.28 | -13.96 | -7.02 | -17.96 | $211,446,068 |
| EXL | Elixinol Wellness | 0.01 | -7.69 | -14.29 | -55.56 | -71.43 | $5,483,896 |
| NSB | Neuroscientific | 0.09 | 3.45 | -14.29 | -3.23 | -65.38 | $12,580,624 |
| CGS | Cogstate Ltd | 1.40 | -3.45 | -14.63 | -37.78 | -24.32 | $246,790,259 |
| IBX | Imagion Biosys Ltd | 0.02 | 13.33 | -15.00 | -32.00 | -56.41 | $20,892,265 |
| PAR | Paradigm Bio. | 0.85 | -0.59 | -15.08 | -44.77 | -40.48 | $242,050,031 |
| PIQ | Proteomics Int Lab | 0.73 | -8.75 | -15.12 | -30.14 | -23.96 | $88,692,673 |
| M7T | Mach7 Tech Limited | 0.78 | -5.49 | -15.30 | 4.73 | 11.51 | $186,007,270 |
| HCT | Holista CollTech Ltd | 0.01 | 0.00 | -15.38 | -38.89 | -71.05 | $3,066,801 |
| OSL | Oncosil Medical | 0.01 | 0.00 | -15.38 | -63.41 | -76.66 | $21,734,252 |
| EPN | Epsilon Healthcare | 0.02 | -12.50 | -16.00 | -16.00 | -40.00 | $6,307,434 |
| TLX | Telix Pharmaceutical | 9.94 | -4.29 | -16.16 | 63.94 | 29.70 | $3,245,468,168 |
| HXL | Hexima | 0.02 | -13.04 | -16.67 | 17.65 | 60.00 | $3,841,911 |
| BP8 | Bph Global Ltd | 0.00 | 25.00 | -16.67 | -81.01 | -81.01 | $3,336,824 |
| RHY | Rhythm Biosciences | 0.43 | 1.19 | -16.67 | -55.26 | -70.69 | $94,994,563 |
| PXS | Pharmaxis Ltd | 0.05 | -10.00 | -18.18 | -19.64 | -40.00 | $31,701,432 |
| PTX | Prescient Ltd | 0.07 | -2.90 | -19.28 | -39.09 | -63.78 | $55,563,616 |
| RGS | Regeneus Ltd | 0.01 | -20.00 | -20.00 | -33.33 | -85.19 | $2,451,495 |
| ANP | Antisense Therapeut. | 0.05 | -1.89 | -20.00 | -44.09 | -52.73 | $43,487,858 |
| RAD | Radiopharm | 0.09 | -5.43 | -20.91 | -35.56 | -59.09 | $21,298,860 |
| RAD | Radiopharm | 0.09 | -5.43 | -20.91 | -35.56 | -59.09 | $21,298,860 |
| PYC | PYC Therapeutics | 0.06 | -1.79 | -21.43 | -20.29 | -20.29 | $209,040,560 |
| IIQ | Inoviq Ltd | 0.69 | -9.21 | -21.59 | 18.97 | 8.66 | $63,492,904 |
| IHL | Incannex Healthcare | 0.09 | 8.05 | -21.67 | -41.25 | -65.19 | $152,352,994 |
| ME1 | Melodiol Glb Health | 0.01 | -12.50 | -22.22 | -61.11 | -82.05 | $17,338,494 |
| ILA | Island Pharma | 0.09 | -5.56 | -22.73 | -29.17 | -55.26 | $6,907,820 |
| NYR | Nyrada Inc. | 0.03 | -3.33 | -23.68 | -76.80 | -82.42 | $4,524,252 |
| VHT | Volpara Health Tech | 0.74 | -7.19 | -24.62 | -7.19 | 6.07 | $194,584,106 |
| BXN | Bioxyne Ltd | 0.02 | -16.67 | -25.00 | -46.43 | 15.38 | $28,524,681 |
| PAB | Patrys Limited | 0.01 | 0.00 | -25.00 | -67.86 | -66.67 | $18,517,026 |
| ADO | Anteotech Ltd | 0.03 | 0.00 | -26.83 | -37.50 | -60.53 | $63,073,217 |
| ACW | Actinogen Medical | 0.03 | -17.97 | -26.84 | -68.89 | -67.77 | $47,222,556 |
| GTG | Genetic Technologies | 0.00 | 0.00 | -33.33 | -42.86 | -60.00 | $23,083,316 |
| MVP | Medical Developments | 0.98 | -0.51 | -34.34 | -25.29 | -50.76 | $85,442,167 |
| IVX | Invion Ltd | 0.01 | -16.67 | -37.50 | -33.33 | -54.55 | $35,318,977 |
| AHK | Ark Mines Limited | 0.22 | -12.24 | -40.28 | 22.86 | -21.82 | $10,383,294 |
| BNO | Bionomics Limited | 0.01 | -4.17 | -45.24 | -64.06 | -77.88 | $16,156,090 |
| RAC | Race Oncology Ltd | 0.86 | -25.22 | -46.08 | -57.00 | -56.78 | $147,577,246 |
| MXC | Mgc Pharmaceuticals | 0.00 | 0.00 | -50.00 | -80.00 | -88.89 | $7,784,719 |
BCAL was the best biotech performer over the past month after announcing breakthrough results from its Precion clinical study in the US.
Results showed that BCAL’s breast cancer diagnostic test achieved an impressive sensitivity of 90%, and a specificity of 85.5%. These results were consistent with the findings of earlier studies conducted in Australia using a different mass spectrometry platform.
BCAL says the replication of these results is a major breakthrough in the path to commercialisation of the BCAL test, with sales expected to commence in the second half of calendar 2024.
Lumos surged after announcing that a core patent covering the camera technology used in its reader platform has been granted for Europe and Japan.
The patent, called “Device for reading an IVD assay”, covers the use of Lumos’ proprietary camera technology which is incorporated in many of its readers.
These readers have become a critical component of new point-of-care tests as they automate the reading and quantification of results, which in turn allows them to be seamlessly integrated into electronic medical record systems.
The latest patent covers the use of Lumos’ reader technology in the European and Japanese markets until 2036. The technology has already been granted in the United States and Australia.
Adherium rose after signing a collaboration agreement with US-based Allergy Partners for asthma management to serve its more than 300,000 patients across 130 sites in 20 states.
Adherium’s Hailie provides real-time data for patient feedback for self-management, and enables doctors to bill remote patients to generate repeat, multi-year revenues.
Initial roll out is for three states, with new employee training starting this month and expansion to more states to follow this calendar year.
The neurodegenerative diseases specialist received a $4.74 million cash refund from the Australian Taxation Office for its R&D activities.
The company says the funds will be used to further Alterity’s clinical research activities, including the ongoing Phase 2 clinical trials for its lead drug candidate ATH434 in Multiple System Atrophy (MSA), a Parkinsonian disorder with no approved therapy.
The wearable nasal and respiratory technology company has received a Notice of Allowance from the US Patent Office relating to the company’s Mute nasal dilator technology.
This application was filed in December 2016, and the approval will now provide further protection to Rhinomed’s family of medical devices which deliver improved sleep, less snoring and better breathing during sleep and aerobic activity.
In the US, Mute is currently sold through leading drug store and grocery chains including Walgreens, CVS, Rite Aid, Ingles Markets and online through Amazon.
Health & Biotech
Health & Biotech
Health & Biotech
Get the latest Stockhead news delivered free to your inbox.
